Stanchart opens second International Banking Centre in Chennai
The Hindu
Standard Chartered launches international banking centre in Chennai for Global Indians, with plans for more centres in key hubs.
Standard Chartered announced the launch of its second international banking centre for Global Indians in Chennai and plans to open more centres in key hubs within the next 12-18 months, said a top official.
“The international banking centre aims to cater to the unique needs of affluent and high net worth individuals by offering tailored cross border investment and wealth lending solutions,” Managing Director, Head of Wealth and Retail Banking India and South India Aditya Mandloi said during an interaction.
“These centres will provide exclusive access to offshore investment opportunities, enabling clients to diversify their portfolios across the global markets,” he said.
Managing Director Head of Private Bank, Affluent and Branch Distribution Network and NRI Nitin Chengappa said that these centres are dedicated spaces within the bank branches focussed on providing cross border wealth solutions. It will provide a multi-market gateway for clients by leveraging its international wealth centres in Singapore, UAE, Hong Kong, Jersey (UK) and India.
Mr. Chengappa said that they are planning to open international banking centres in Kolkata, New Delhi and in niche markets such as Kerala, Punjab and Gujarat in 12-18 months.
Equity markets decline on weak earnings, global trends; inflation hits 14-month high, foreign funds exit, oil prices rise.
Swiggy IPO debuts with a 7.69% jump at NSE, market valuation at ₹89,549.08 crore; shares listed at ₹412 on BSE.
Shares in Samsung Electronics fell on Wednesday to their lowest level in more than four years.
Mercedes-Benz India introduces the new Mercedes-AMG C 63 S E Performance sportscar with hybrid powertrain and innovative business model.
Hyundai Motor India Ltd. reports 16% profit decline in Q3 due to market sentiments, geopolitical factors, and Red Sea crisis.
Equity market plunges over 800 points, eroding market capitalisation by ₹5.29 lakh crore amid global economic concerns.
Aurobindo Pharma's CuraTeQ Biologics receives EMA GMP certificate for biosimilars, paving way for European approvals of three products.
BCCI to withdraw insolvency plea against Byju's after Supreme Court sets aside NCLAT judgement, NCLT hearing scheduled.
Natco Pharma's Q2 profits soar 83% to ₹676.5 crore, driven by robust exports and stable domestic business.
India's industrial output rebounds with 3.1% growth in September, led by manufacturing, despite weak electricity and mining sectors.
India's retail inflation hits 6.2% in October, driven by a 10.9% spike in food prices, breaching RBI's upper limit.